Ron Squarer

Insider Reports History

Entity
Individual
Location
C/O Adc Therapeutics Sa, Biopole, Route De La Corniche 3 B, Epalinges, Switzerland
Signature
Lisa Kallebo, as Attorney-in-Fact for Ron Squarer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ron Squarer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ADC Therapeutics SA Director Common Shares 80.7K $233K $2.89 Jun 17, 2024 Direct
Travere Therapeutics, Inc. Director Common Stock 28.9K $195K $6.74 May 8, 2024 Direct
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 Jun 11, 2024 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19.5K May 8, 2024 Direct

Insider Reports Filed by Ron Squarer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADCT ADC Therapeutics SA Jun 17, 2024 1 -$20.2K 4 Jun 18, 2024 Director
ADCT ADC Therapeutics SA Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
NA Deciphera Pharmaceuticals, Inc. Jun 11, 2024 5 $0 4 Jun 11, 2024 Director
TVTX Travere Therapeutics, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 16, 2024 1 $50K 4 Jan 18, 2024 Director
ADCT ADC Therapeutics SA Jan 2, 2024 0 $0 3 Jan 2, 2024 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
TVTX Travere Therapeutics, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 17, 2023 1 $50K 4 Jan 19, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
TVTX Travere Therapeutics, Inc. May 11, 2022 2 $0 4 May 12, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 18, 2022 1 $50K 4 Jan 20, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Director
TVTX Travere Therapeutics, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director